DOI: 10.4244/EIJV8SPA23

Stent for Life project: present situation in Turkey

Ömer Göktekin1*, MD; Gökhan Ertaş1, MD; Ümit Kervan2, MD; Orhan Koç3, MD; Ömer Kozan4, MD

Abstract

The rate of percutaneous coronary intervention for acute ST-segment elevation myocardial infarction varies between European countries. The variations arise partly because of differences between countries in the primary percutaneous coronary intervention network system. The lack of an organised primary percutaneous coronary intervention network system in Turkey was the main reason for the low rate of primary percutaneous coronary intervention in Turkey. The Stent for Life project has increased the awareness of the importance of the prompt treatment of ST-segment elevation myocardial infarction in our country. Primary percutaneous coronary intervention has emerged as the preferred reperfusion strategy for patients with ST-segment elevation myocardial infarction in pilot cities after three years of Stent for Life project. In the present manuscript, we aim to summarise the current situation and the targets of the Stent for Life project in Turkey.

Introduction

Historically, access to the use of primary percutaneous coronary intervention (p-PCI) in acute ST-segment elevation myocardial infarction (STEMI) patients in Turkey has been low. In 2010, patient access to p-PCI was 8% in acute STEMI patients1. Thrombolysis was the dominant reperfusion strategy before the Stent for Life (SFL) project. Turkey has participated in the SFL project since 2009 initiating SFL in 18 pilot cities. Good progress has been achieved since that time. The number of p-PCI has increased significantly year after year. It has created a specific collaboration protocol between p-PCI centres, ambulances and emergency systems in the STEMI networks.

Current status of the SFL project

The SFL project was implemented in collaboration with our Ministry of Health and the Turkish Society of Cardiology. Successful collaboration has been achieved during the project and the Ministry of Health have supported the SFL project very strongly. The project targets were very clear. We have set up a network to reach those targets. The three main targets were: 1) to increase the use of p-PCI in more than 70% of all STEMI patients; 2) to achieve p-PCI rates of more than 600 per million inhabitants per year; and 3) that all existing p-PCI centres should offer a 24-hour p-PCI service seven days a week (24/7). Mortality from STEMI is lower in countries with p-PCI dominance than in countries where thrombolysis represents the treatment of choice2,3. We therefore aimed to reduce the mortality from STEMI through participating in the SFL project.

Cities were divided into three areas: the p-PCI area, a thrombolytic area covered by the cardiologist, and a thrombolytic area covered by the interventionalist (Figure 1). At the beginning of the SFL project, we established pilot cities and we set up a STEMI network. There was no consensus between emergency medical systems and first medical contact centres. No transport-chain protocol had been proposed previously by the Ministry of Health in Turkey. Patients being admitted to public hospitals were transported to non-PCI centres due to a lack of communication between first contact emergency medical systems and the hospitals. After the implementation of the SFL project in collaboration with our Ministry of Health, direct communication between emergency medical systems, ambulances and PCI centres prior to admission was achieved.

Figure 1. A primary percutaneous coronary intervention (p-PCI) colour map which was divided into three areas: p-PCI area, thrombolytic area covered by a cardiologist, thrombolytic area covered by an interventionalist.

In the pilot cities, after the SFL project started, the primary PCI rate reached over 90% in three years (Figure 2). In the last five years, the number of ambulances and emergency stations has been increased by the Ministry of Health, resulting in a marked increase in the number of cases reached by emergency medical systems and brought to hospital. The average time to arrival at the patient’s side was 12 minutes in the city area. In the pilot cities, the emergency medical system (ambulance) brings the STEMI patient directly to the p-PCI centre. The education of ambulance doctors and emergency doctors was started locally by experienced cardiologists. The percentage of STEMI patients arriving to the first hospital via ambulance services has increased from 20 to 77.33%1.

Figure 2. Primary percutaneous coronary intervention (p-PCI) in acute ST-segment elevation myocardial infarction.

Time from the onset of symptoms to p-PCI seems to correlate directly with mortality rates4. Efficiency has also increased within hospitals with a mean door-to-balloon time for the pilot cities of 54.72±43.66 minutes (Table 1). Although door-to-balloon times have shortened progressively over the years, the time duration between onset of symptoms and transport of STEMI patients to PCI centres remains long. Consequently, it has been decided to increase awareness of the importance of the prompt treatment of STEMI. There has been no nationwide public campaign related to heart attack and p-PCI as yet, due to the incompleteness of p-PCI organisation in all regions of the country. However, local public campaigns have been started in two cities as part of the SFL project. Simulation courses for revascularisation techniques in acute STEMI have been organised for three years (one course per month) for young cardiologists. It has been reported that drug-eluting stents can safely be used in cases of STEMI5. However, bare metal stents were used in 87.3% of primary PCI cases and the use of drug-eluting stents was 8.11% in our country.

Barriers still to overcome

The main barriers to overcome in Turkey are that there are insufficient nurses and technicians for 24/7 PCI, especially in university hospital cathlabs, and an absence of additional payment to cardiologists for primary angioplasty. Therefore, only 57% of p-PCI centres can offer a 24-hour p-PCI service seven days per week. Time from symptom onset to first medical contact remains long due to lack of awareness of myocardial infarction.

Conclusion

Primary PCI has emerged as the preferred reperfusion strategy for patients with STEMI in pilot cities after three years of the SFL project. To date, no investigations into the medical transport chain and transport durations have been conducted nationwide. We have taken a snapshot of the country concerning STEMI management and we have also collected data regarding p-PCI rates and treatment strategies from the SFL project.

Conflict of interest statement

The authors have no conflicts of interest to declare.


References

Volume 8 Supplement P
Aug 25, 2012
Volume 8 Supplement P
View full issue


Key metrics

On the same subject

Editorial

10.4244/EIJ-E-23-00052 Mar 18, 2024
Comparative preclinical assessment of drug-coated balloons: a blessing and a curse for clinical translation
Joner M and Wild L
free

Debate

10.4244/EIJ-E-24-00005 Mar 18, 2024
Ischaemic and viability testing for guiding PCI are overrated: pros and cons
McEntegart M et al
free

Original Research

10.4244/EIJ-D-23-00725 Mar 18, 2024
A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study
Rosseel L et al

Original Research

10.4244/EIJ-D-23-00783 Mar 18, 2024
Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failure
Meier D et al
Trending articles
281.88

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
243.2

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
208.35

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.7

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al
free
167.05

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
151.03

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
110.35

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved